Compare StocksDGX vs MS

Quest Diagnostics Incorporated (DGX) vs Morgan Stanley (MS): Which Is the Better Buy in 2026?

As of 2026-06-21, DGX is overvalued at $195, with a DCF intrinsic value of $154 and a margin of safety of -27%. MS is undervalued at $223, with an intrinsic value of $298 and a margin of safety of 25%. Of the two, MS has the wider margin of safety.

DGX
Quest Diagnostics Incorporated
$195.00
VS
MS
Morgan Stanley
$223.17

Rewards

DGX
  • 4 insider purchases vs. 1 sell in the past 3 months — buying activity significantly outweighs selling.
MS
  • Gross margin of 87.4% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Morgan Stanley scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Each dollar of retained earnings has created $3.56 of earning power — management is an exceptional capital allocator.

Risks

DGX
  • Each dollar of retained earnings has produced only $0.36 of earning power — shareholders may have been better served by dividends.
  • FCF yield of 6.3% suggests reasonable valuation assuming continued moderate growth.
MS
  • Trailing P/E of 20.2x is 26% above the historical average of 16.1x — the stock trades at a premium to its own history.
  • PEG ratio of 2.68 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.29 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
DGX
MS
Valuation
$1.36B
Free Cash Flow
N/A
6.30%
FCF Yield
N/A
21.55
Trailing P/E
20.20
16.71
Forward P/E
17.56
Quality & Moat
8.94%
ROIC
3.38%
14.54%
ROE
16.39%
33.28%
Gross Margin
87.39%
1.50
PEG Ratio
2.68
Balance Sheet Safety
0.78
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.70
Net Debt / EBITDA
N/A
1.76%
Dividend Yield
1.79%
DGX: 2Ties: 3MS: 4
DGXMS

Historical Fundamentals

Learn more →
DGX

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

MS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
DGX
$1.03
created per $1 retained over 3 years
Value Creator
Σ Retained
$1.72B
Δ Market Cap
+$1.77B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
MS
$6.65
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$20.84B
Δ Market Cap
+$138.59B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
DGX
26.6% Overvalued
Price is 26.6% above estimated fair value
Current Price: $195.00
Fair Value: $154.08
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
MS
25.0% Margin of Safety
Price is 25.0% below estimated fair value
Current Price: $223.17
Fair Value: $297.53
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
DGX

What growth rate is the market pricing in at $195?

+11.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +7.9%

The market implies +11.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +7.9%, reflecting heavy growth investment.

MS

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
DGX
56/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
MS
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
DGX
-2.66
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
MS
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
DGX
Insiders 0.4%Institutions 97.9%Retail & Other 1.7%
No. of Institutional Holders1,478
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
MS
Insiders 24.3%Institutions 62.8%Retail & Other 12.9%
No. of Institutional Holders3,209
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
DGX
4
Buys (3M)
14
Buys (12M)
Total value (12M): $79,709
LASSITER WRIGHT III
Director
$1,168
@ $194.67 · 2026-04-20
KUPPUSAMY KARTHIK
Officer
$7,593
@ $194.69 · 2026-04-20
DELANEY MARK E
Officer
$7,204
@ $194.70 · 2026-04-20
PLEWMAN PATRICK
Officer
$9,540
@ $194.69 · 2026-04-20
LASSITER WRIGHT III
Director
$1,285
@ $183.57 · 2026-01-28
KUPPUSAMY KARTHIK
Officer
$2,936
@ $183.50 · 2026-01-28
DELANEY MARK E
Officer
$2,753
@ $183.53 · 2026-01-28
GREGG VICKY B
Director
$12,295
@ $183.51 · 2026-01-28
CARTER ROBERT B
Director
$1,101
@ $183.50 · 2026-01-28
LASSITER WRIGHT III
Director
$1,173
@ $167.57 · 2025-07-21
KUPPUSAMY KARTHIK
Officer
$4,522
@ $167.48 · 2025-07-21
DELANEY MARK E
Officer
$2,847
@ $167.47 · 2025-07-21
GREGG VICKY B
Director
$13,232
@ $167.49 · 2025-07-21
SAMAD SAMER ABDUL
Chief Financial Officer
$12,060
@ $167.50 · 2025-07-21
KUPPUSAMY KARTHIK
Officer
$4,439
@ $164.41 · 2025-04-21
DELANEY MARK E
Officer
$4,111
@ $164.44 · 2025-04-21
PLEWMAN PATRICK
Officer
$13,318
@ $164.42 · 2025-04-21
SAMAD SAMER ABDUL
Chief Financial Officer
$12,167
@ $164.42 · 2025-04-21
KUPPUSAMY KARTHIK
Officer
$1,896
@ $158.00 · 2025-01-29
DELANEY MARK E
Officer
$632.00
@ $158.00 · 2025-01-29
PLEWMAN PATRICK
Officer
$9,008
@ $158.04 · 2025-01-29
GREGG VICKY B
Director
$11,379
@ $158.04 · 2025-01-29
SAMAD SAMER ABDUL
Chief Financial Officer
$5,531
@ $158.03 · 2025-01-29
KUPPUSAMY KARTHIK
Officer
$3,137
@ $149.38 · 2024-10-21
DELANEY MARK E
Officer
$598.00
@ $149.50 · 2024-10-21
PLEWMAN PATRICK
Officer
$8,962
@ $149.37 · 2024-10-21
GREGG VICKY B
Director
$11,352
@ $149.37 · 2024-10-21
SAMAD SAMER ABDUL
Chief Financial Officer
$5,527
@ $149.38 · 2024-10-21
Open market purchases · includes direct & indirect ownership · excludes option exercises
MS
0
Buys (3M)
1
Buys (12M)
Total value (12M): $5,630
PETERSON DOUGLAS L
Director
$5,630
@ $156.39 · 2025-10-17
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
DGX
1
Sells (3M)
24
Sells (12M)
Total value (12M): $34.53M
KUPPUSAMY KARTHIK
Officer
$1.63M
@ $200.00 · 2026-06-04
PLEWMAN PATRICK
Officer
$588,730
@ $206.21 · 2026-03-05
DOHERTY CATHERINE T
Officer
$1.15M
@ $206.21 · 2026-03-05
PREVOZNIK MICHAEL E
General Counsel
$799,682
@ $206.21 · 2026-03-05
KUPPUSAMY KARTHIK
Officer
$538,372
@ $204.86 · 2026-03-04
PLEWMAN PATRICK
Officer
$85,169
@ $207.73 · 2026-03-03
DOHERTY CATHERINE T
Officer
$131,285
@ $207.73 · 2026-03-03
PREVOZNIK MICHAEL E
General Counsel
$109,266
@ $207.73 · 2026-03-03
PLEWMAN PATRICK
Officer
$196,227
@ $204.83 · 2026-02-19
DOHERTY CATHERINE T
Officer
$293,521
@ $204.83 · 2026-02-19
PREVOZNIK MICHAEL E
General Counsel
$227,566
@ $204.83 · 2026-02-19
DOHERTY CATHERINE T
Officer
$5.39M
@ $206.15 · 2026-02-13
PLEWMAN PATRICK
Officer
$1.16M
@ $204.00 · 2026-02-10
GREGG VICKY B
Director
$239,700
@ $191.76 · 2025-11-25
DAVIS J E CAUSEY
Chief Executive Officer
$10.59M
@ $192.22 · 2025-11-25
DELANEY MARK E
Officer
$1.49M
@ $187.35 · 2025-11-18
PFEIFFER GARY M
Director
$270,317
@ $182.40 · 2025-10-22
PREVOZNIK MICHAEL E
General Counsel
$42,706
@ $188.13 · 2025-09-26
PREVOZNIK MICHAEL E
General Counsel
$5.33M
@ $187.12 · 2025-09-24
PLEWMAN PATRICK
Officer
$365,375
@ $185.00 · 2025-08-21
PLEWMAN PATRICK
Officer
$829,356
@ $183.00 · 2025-08-19
PLEWMAN PATRICK
Officer
$355,500
@ $180.00 · 2025-08-15
PLEWMAN PATRICK
Officer
$968,625
@ $175.00 · 2025-08-06
KUPPUSAMY KARTHIK
Officer
$1.76M
@ $167.95 · 2025-07-31
DELANEY MARK E
Officer
$306,800
@ $175.51 · 2025-05-13
KUPPUSAMY KARTHIK
Officer
$434,350
@ $170.00 · 2025-04-02
DAVIS JAMES E
Chief Executive Officer
$6.60M
@ $168.46 · 2025-04-02
PREVOZNIK MICHAEL E
General Counsel
$789,310
@ $170.00 · 2025-03-17
DOHERTY CATHERINE T
Officer
$935,078
@ $174.13 · 2025-03-05
DOHERTY CATHERINE T
Officer
$125,866
@ $175.79 · 2025-03-04
PREVOZNIK MICHAEL E
General Counsel
$104,068
@ $175.79 · 2025-03-04
DOHERTY CATHERINE T
Officer
$142,231
@ $172.61 · 2025-02-27
PREVOZNIK MICHAEL E
General Counsel
$91,138
@ $172.61 · 2025-02-27
DOHERTY CATHERINE T
Officer
$244,515
@ $170.51 · 2025-02-20
PREVOZNIK MICHAEL E
General Counsel
$103,278
@ $170.99 · 2025-02-20
PLEWMAN PATRICK
Officer
$54,307
@ $169.71 · 2025-02-19
DELANEY MARK E
Officer
$66,214
@ $164.30 · 2025-02-05
GREGG VICKY B
Director
$205,710
@ $164.57 · 2025-02-05
PREVOZNIK MICHAEL E
General Counsel
$5.73M
@ $163.07 · 2024-11-29
DOHERTY CATHERINE T
Officer
$5.40M
@ $162.99 · 2024-11-27
DEPPE MICHAEL J
Officer
$2.89M
@ $154.05 · 2024-11-06
KUPPUSAMY KARTHIK
Officer
$278,525
@ $156.92 · 2024-10-28
PREVOZNIK MICHAEL E
General Counsel
$5.04M
@ $154.97 · 2024-08-29
KUPPUSAMY KARTHIK
Officer
$304,990
@ $153.26 · 2024-08-28
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
MS
4
Sells (3M)
16
Sells (12M)
Total value (12M): $70.42M
GROSSMAN ERIC F
Officer
$2.12M
@ $190.75 · 2026-04-20
SIMKOWITZ DANIEL A
President
$2.78M
@ $189.24 · 2026-04-17
CRAWLEY MANDELL L.
Officer
$3.04M
@ $188.22 · 2026-04-16
SAPERSTEIN ANDREW MICHAEL
President
$9.74M
@ $188.59 · 2026-04-16
SIMKOWITZ DANIEL A
President
$6.02M
@ $182.61 · 2026-01-30
CRAWLEY MANDELL L.
Officer
$1.44M
@ $183.45 · 2026-01-20
YESHAYA SHARON
Chief Financial Officer
$2.94M
@ $185.77 · 2026-01-20
SMITH CHARLES AUBREY III
Officer
$1.55M
@ $182.08 · 2026-01-20
GROSSMAN ERIC F
Officer
$3.97M
@ $184.00 · 2026-01-20
PIZZI MICHAEL A
Officer
$3.69M
@ $184.55 · 2026-01-20
SAPERSTEIN ANDREW MICHAEL
President
$5.57M
@ $183.62 · 2026-01-20
PICK EDWARD N.
Chief Executive Officer
$16.43M
@ $164.34 · 2025-10-31
SIMKOWITZ DANIEL A
President
$4.09M
@ $141.13 · 2025-07-17
SMITH CHARLES AUBREY III
Officer
$2.81M
@ $140.30 · 2025-07-17
GROSSMAN ERIC F
Officer
$1.69M
@ $141.12 · 2025-07-17
PIZZI MICHAEL A
Officer
$2.53M
@ $140.62 · 2025-07-17
SIMKOWITZ DANIEL A
President
$3.70M
@ $127.37 · 2025-05-12
HERZ ROBERT H
Director
$95,459
@ $119.32 · 2025-05-02
SAPERSTEIN ANDREW MICHAEL
President
$4.80M
@ $120.00 · 2025-05-02
GROSSMAN ERIC F
Officer
$1.12M
@ $111.65 · 2025-04-15
CRAWLEY MANDELL L.
Officer
$1.15M
@ $138.06 · 2025-01-22
SIMKOWITZ DANIEL A
President
$5.00M
@ $136.61 · 2025-01-21
AKRAM RAJA
Chief Financial Officer
$2.38M
@ $136.01 · 2025-01-21
GROSSMAN ERIC F
Officer
$1.78M
@ $136.20 · 2025-01-21
PIZZI MICHAEL A
Officer
$2.52M
@ $136.92 · 2025-01-21
SAPERSTEIN ANDREW MICHAEL
President
$4.20M
@ $136.43 · 2025-01-21
CRAWLEY MANDELL L.
Officer
$368,375
@ $105.25 · 2024-07-26
AKRAM RAJA
Officer
$797,764
@ $106.37 · 2024-07-18
SIMKOWITZ DANIEL A
President
$4.26M
@ $106.54 · 2024-07-17
HERZ ROBERT H
Director
$106,621
@ $106.62 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
DGX
FearGreed
😐Neutral(57/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
MS
FearGreed
😏Greed(70/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
DGX
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (57)
MS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (70)
View DGX Full AnalysisView MS Full Analysis

Frequently Asked Questions: DGX vs MS

Is Quest Diagnostics Incorporated or Morgan Stanley more undervalued in 2026?

Based on our discounted cash flow model, MS trades at a 25.0% margin of safety (intrinsic value $298 vs. price $223), compared to DGX's -26.6% margin of safety (intrinsic $154 vs. $195).

Which stock has a wider economic moat, Quest Diagnostics Incorporated or Morgan Stanley?

MS scores 80/100 (Wide moat), while DGX scores 56/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Morgan Stanley in financial distress?

MS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. DGX scores 3.1 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Quest Diagnostics Incorporated or Morgan Stanley?

DGX earns 8.9% ROIC versus MS's 3.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Quest Diagnostics Incorporated's or Morgan Stanley's?

DGX's dividend earns a safety score of 94/100 (Very Safe), compared to MS's 79/100 (Safe). DGX has raised its dividend for 3 consecutive years.